Johansen; Nils Langeland
Patent Applications and Registrations
Patent applications and USPTO patent grants for Johansen; Nils Langeland.The latest application filed is for "growth hormones with prolonged in-vivo efficacy".
Company Profile
3.19.34
- Johansen; Nils Langeland - Koebenhavn OE DK
- Johansen; Nils Langeland - Copenhagen OE DK
- Johansen; Nils Langeland - Koebenhavn O N/A DK
- JOHANSEN; NILS LANGELAND - COPENHAGEN O DK
- Johansen; Nils Langeland - Kobenhavn O DK
- Johansen; Nils Langeland - Kobenhavn DK
- Johansen; Nils Langeland - Kobenhavn 0 DK
- Johansen; Nils Langeland - Bagsvaerd DK
- Johansen; Nils Langeland - Copenhagen DK
- Johansen; Nils Langeland - Coppenhagen DK
- Johansen; Nils Langeland - DK-2100 Copenhagen .O slashed. DK
- Johansen; Nils Langeland - Herlev DK
- Johansen; Nils Langeland - K.o slashed.benhavn .o slashed. DK
Patent Activity
| Patent | Date |
|---|---|
| Protein conjugates Grant 11,292,825 - Clo , et al. April 5, 2 | 2022-04-05 |
| Growth Hormones with Prolonged In-Vivo Efficacy App 20200306382 - Andersen; Henrik Sune ; et al. | 2020-10-01 |
| Growth Hormones with Prolonged In-Vivo Efficacy App 20200102568 - Behrens; Carsten ; et al. | 2020-04-02 |
| Growth Hormones with Prolonged In-Vivo Efficacy App 20190203213 - Behrens; Carsten ; et al. | 2019-07-04 |
| Protein Conjugates App 20180282387 - Clo; Emiliano ; et al. | 2018-10-04 |
| Growth Hormones with Prolonged In-Vivo Efficacy App 20180221501 - Andersen; Henrik Sune ; et al. | 2018-08-09 |
| GLP-1 compounds Grant 9,920,106 - Johansen , et al. March 20, 2 | 2018-03-20 |
| Growth Hormones with Prolonged In-Vivo Efficacy App 20170239362 - Behrens; Carsten ; et al. | 2017-08-24 |
| Growth hormones with prolonged in-vivo efficacy Grant 9,695,226 - Behrens , et al. July 4, 2 | 2017-07-04 |
| Transglutaminase Mediated Conjugation Of Peptides App 20160355859 - JOHANSEN; NILS LANGELAND ; et al. | 2016-12-08 |
| Growth Hormone Compounds App 20160017017 - Zhao; Xin ; et al. | 2016-01-21 |
| Growth Hormones with Prolonged In-Vivo Efficacy App 20140329750 - Andersen; Henrik Sune ; et al. | 2014-11-06 |
| Conjugated proteins with prolonged in vivo efficacy Grant 8,865,868 - Behrens , et al. October 21, 2 | 2014-10-21 |
| Growth hormones with prolonged in-vivo efficacy Grant 8,841,249 - Johansen , et al. September 23, 2 | 2014-09-23 |
| Growth hormones with prolonged in-vivo efficacy Grant 8,779,109 - Behrens , et al. July 15, 2 | 2014-07-15 |
| Growth Hormones with Prolonged In-Vivo Efficacy App 20140107324 - Behrens; Carsten ; et al. | 2014-04-17 |
| Novel Glp-1 Derivatives App 20130053315 - Lau; Jesper ; et al. | 2013-02-28 |
| Albumin-binding Conjugates Comprising Fatty-acid And Peg App 20130040884 - Lau; Jesper ; et al. | 2013-02-14 |
| Growth Hormones With Prolonged In-Vivo Efficacy App 20120309944 - Behrens; Carsten ; et al. | 2012-12-06 |
| Novel Glp-1 Compounds App 20120289453 - Johansen; Nils Langeland ; et al. | 2012-11-15 |
| Growth Hormones with Prolonged In-Vivo Efficacy App 20120172303 - Johansen; Nils Langeland ; et al. | 2012-07-05 |
| Growth Hormone Conjugate with Increased Stability App 20110263501 - Johansen; Nils Langeland | 2011-10-27 |
| Novel GLP-1 Derivatives App 20100305032 - Lau; Jesper ; et al. | 2010-12-02 |
| Modulating Enzymatic Processes by Addition of Diolcontaining Substances App 20100009917 - Buchardt; Jens ; et al. | 2010-01-14 |
| Transglutaminase Mediated Conjugation of Peptides App 20090264366 - Johansen; Nils Langeland ; et al. | 2009-10-22 |
| Conjugation of Peptides App 20090253166 - Zundel; Magali A. ; et al. | 2009-10-08 |
| Transglutaminase Variants with Improved Specificity App 20090117640 - Norskov-Lauritsen; Leif ; et al. | 2009-05-07 |
| Selectively conjugated peptides and methods of making the same Grant 7,524,813 - Zundel , et al. April 28, 2 | 2009-04-28 |
| Melanocortin receptor agonists Grant 7,517,854 - Conde-Frieboes , et al. April 14, 2 | 2009-04-14 |
| Hybrid molecules having Factor VII/VIIa activity Grant 7,432,352 - Johansen October 7, 2 | 2008-10-07 |
| GLP-2 compounds, formulations, and uses thereof Grant 7,411,039 - Thim , et al. August 12, 2 | 2008-08-12 |
| Growth Hormone Conjugates App 20080182783 - Dorwald; Florencio Zaragoza ; et al. | 2008-07-31 |
| Osteogenic Growth Peptide Fusion Proteins App 20080064630 - Blume; Niels ; et al. | 2008-03-13 |
| Novel Glp-1 Derivatives App 20070203058 - Lau; Jesper ; et al. | 2007-08-30 |
| Conjugation of peptides App 20070111926 - Zundel; Magali A. ; et al. | 2007-05-17 |
| Transglutaminase mediated conjugation of peptides App 20070105770 - Johansen; Nils Langeland ; et al. | 2007-05-10 |
| Novel GLP-1 compounds App 20070042956 - Johansen; Nils Langeland ; et al. | 2007-02-22 |
| Novel Melanocortin Receptor Agonists App 20070027091 - Conde-Frieboes; Kilian Waldemar ; et al. | 2007-02-01 |
| Hybird molecules having factor VII/VIIa activity App 20060258851 - Johansen; Nils Langeland | 2006-11-16 |
| GLP-2 derivatives App 20060105948 - Kodra; Janos Tibor ; et al. | 2006-05-18 |
| GLP-2 compounds, formulations, and uses thereof App 20040122210 - Thim, Lars ; et al. | 2004-06-24 |
| Compounds with growth hormone releasing properties Grant 6,127,341 - Hansen , et al. October 3, 2 | 2000-10-03 |
| Compounds with growth hormone releasing properties Grant 6,013,658 - Lau , et al. January 11, 2 | 2000-01-11 |
| Nociceptin analogues Grant 5,998,375 - Th.o slashed.gersen , et al. December 7, 1 | 1999-12-07 |
| Compounds with growth hormone releasing properties Grant 5,990,084 - Richter , et al. November 23, 1 | 1999-11-23 |
| Compounds with growth hormone releasing properties Grant 5,854,211 - Johansen , et al. December 29, 1 | 1998-12-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 